| Financial Year |
March 31 2023 |
| Monetary Funds |
1,384,613,970.18 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
144,160,747.77 |
| Accounts Receivable |
2,712,747,071.65 |
| Advances to Suppliers |
155,433,632.72 |
| Other Receivables |
71,602,959.23 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
1,741,630,430.02 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
84,006,735.04 |
| Other Current Assets |
171,262,001.05 |
| Total Current Assets |
6,559,458,604.47 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
417,424,948.82 |
| Long-term Equity Investment |
30,349,398.12 |
| Investment Properties |
18,445,065.61 |
| Fixed Assetes |
1,042,430,984.29 |
| Under-construction Projects |
617,280,841.51 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
1,418,189,044.22 |
| R&D expenses |
470,272,495.97 |
| Goodwill |
98,676,651.76 |
| Long-Term Deferred and Prepaid Expenses |
39,261,977.52 |
| Deferred Income Tax Assets |
687,625,680.24 |
| Other Non-Current Assets |
174,262,112.13 |
| Sub-Total of Non-Current Assets |
5,087,762,854.32 |
| Total Assets |
11,647,221,458.79 |
| Short-Term Loans |
1,859,577,671.30 |
| Trading Financial liabilities |
-- |
| Notes Payable |
296,066,498.48 |
| Accounts Payable |
973,570,341.41 |
| Accounts Received In Advance |
5,500,000.00 |
| Employee Compensation Payable |
118,779,699.90 |
| Taxes Payable |
86,734,717.78 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
174,247,537.91 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
437,917,133.06 |
| Other Current Liabilities |
71,344,525.65 |
| Sub-Total of Current Liabilities |
4,506,635,074.74 |
| Long-term Loans |
172,575,511.27 |
| Bonds Payable |
359,196,701.96 |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
132,983,639.89 |
| Deferred Income Tax Liabilities |
105,104,946.70 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
862,622,779.37 |
| Total Liabilities |
5,369,257,854.11 |
| Paid-In Capital(Or Share Stock) |
1,816,079,691.00 |
| Capital Surplus |
2,834,204,725.33 |
| Surplus Reserve |
170,975,251.73 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
1,257,623,104.71 |
| Minority Stockholder's Interest |
154,566,264.14 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
6,123,397,340.54 |
| Owner's Equity（Stockholder's Equity） |
6,277,963,604.68 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
11,647,221,458.79 |
